New DMSO combo therapy aims to quiet tinnitus in long COVID patients
NCT ID NCT07567274
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This pilot study tests a DMSO-based ear drop and cream for adults with chronic tinnitus linked to long COVID or COVID-19 vaccine injury. Twenty participants will use both treatments for 30 days. The main goal is to see if at least half of them get a 50% or greater reduction in tinnitus-related handicap. All visits are done remotely after an initial in-person check.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SUBJECTIVE TINNITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.